| Dr Ellen Elizabeth Michalowski, MD | |
|
142 W Main St, Fort Kent, ME 04743-1230 | |
| (207) 834-1161 | |
| (207) 834-3285 |
| Full Name | Dr Ellen Elizabeth Michalowski |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 142 W Main St, Fort Kent, Maine |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548286156 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 014320 (Maine) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ellen Elizabeth Michalowski, MD 194 E Main St, Fort Kent, ME 04743-1428 Ph: (207) 834-1161 | Dr Ellen Elizabeth Michalowski, MD 142 W Main St, Fort Kent, ME 04743-1230 Ph: (207) 834-1161 |
News Archive
Neuroscience research at the University of Sheffield has been recognized by Her Majesty The Queen for delivering real benefits in improving patient outcomes for people living with some of the most devastating neurodegenerative diseases.
An international scientific team has developed a new small molecule -VH298- which can provoke a hypoxic response controlled from outside the cells, according to a study recently published in the magazine Nature Communications with its first authors being the expert Carles Galdeano, Beatriu de Pinós researcher at the Department of Pharmacy and Pharmaceutical Technology and Physical Chemistry of the Faculty of Pharmacy and Food Sciences and the Institute of Biomedicine of the University of Barcelona, and Julianty Frost, from the University of Dundee.
Sucampo Pharmaceuticals, Inc. today announced that the Company received a supplement approval from the U.S. Food and Drug Administration (FDA) that removes pregnancy "warnings and precautions" and clarifies information regarding the use of AMITIZA (lubiprostone) by pregnant and/or nursing women. In addition, the FDA expanded the labeling text of the Mechanism of Action section in the prescribing information for AMITIZA.
A physician at Scripps Health's Prebys Cardiovascular Institute has become the first in the Western United States to treat heart attack patients with a new supersaturated oxygen (SSO2) system in an attempt to reduce permanent damage to their heart muscle.
› Verified 6 days ago
Paul H. Mcbreairty, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 468 St John Rd, Fort Kent, ME 04743 Phone: 207-834-5330 |